These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 37227492)

  • 41. Relapsed/Refractory T- Acute Lymphoblastic Leukemia - Current Options and Future Directions.
    Jeha S
    Indian J Pediatr; 2024 Feb; 91(2):168-175. PubMed ID: 37642889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma and acute biphenotypic leukemias.
    Han X; Bueso-Ramos CE
    Am J Clin Pathol; 2007 Apr; 127(4):528-44. PubMed ID: 17369128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical use of CAR T-cells in treating acute lymphoblastic leukemia.
    Korkmaz S
    Transfus Apher Sci; 2023 Apr; 62(2):103666. PubMed ID: 36868895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status and future directions of T-lymphoblastic lymphoma in children and adolescents.
    Burkhardt B; Mueller S; Khanam T; Perkins SL
    Br J Haematol; 2016 May; 173(4):545-59. PubMed ID: 26991119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CAR T Cell Therapy in Acute Lymphoblastic Leukemia and Potential for Chronic Lymphocytic Leukemia.
    Singh N; Frey NV; Grupp SA; Maude SL
    Curr Treat Options Oncol; 2016 Jun; 17(6):28. PubMed ID: 27098534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coincidence of de novo T-lymphoblastic lymphoma and cutaneous gamma/delta peripheral T-cell lymphoma.
    Satoh T; Kayano H; Kohri M; Tanae K; Asou C; Takahashi N; Tsukasaki K; Yasuda M
    J Clin Exp Hematop; 2023; 63(4):257-261. PubMed ID: 38148016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current and emerging therapeutic approaches for T-cell acute lymphoblastic leukaemia.
    Pocock R; Farah N; Richardson SE; Mansour MR
    Br J Haematol; 2021 Jul; 194(1):28-43. PubMed ID: 33942287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical features and treatment outcomes of adult B- and T-lymphoblastic lymphoma: results of multicentre analysis in Korea.
    Chang MH; Kim SJ; Kim K; Oh SY; Lee DH; Huh J; Ko YH; Choi CW; Yang DH; Won JH; Kim WS; Suh C
    Leuk Lymphoma; 2009 Jul; 50(7):1119-25. PubMed ID: 19557632
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphoblastic lymphoma in children and adolescents: review of current challenges and future opportunities.
    Burkhardt B; Hermiston ML
    Br J Haematol; 2019 Jun; 185(6):1158-1170. PubMed ID: 30809797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies.
    Cooper ML; DiPersio JF
    Best Pract Res Clin Haematol; 2019 Dec; 32(4):101097. PubMed ID: 31779968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facts and Challenges in Immunotherapy for T-Cell Acute Lymphoblastic Leukemia.
    Bayón-Calderón F; Toribio ML; González-García S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically heterogeneous mouse model of T-cell acute lymphoblastic leukemia.
    Gao J; Van Meter M; Hernandez Lopez S; Chen G; Huang Y; Ren S; Zhao Q; Rojas J; Gurer C; Thurston G; Kuhnert F
    Dis Model Mech; 2019 Sep; 12(9):. PubMed ID: 31399482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
    Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH
    Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
    Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
    Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
    Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
    Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Bright Horizon: Immunotherapy for Pediatric T-Cell Malignancies.
    Newman H; Teachey DT
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955734
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The future of cellular immunotherapy for childhood leukemia.
    Bonifant CL; Tasian SK
    Curr Opin Pediatr; 2020 Feb; 32(1):13-25. PubMed ID: 31851053
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD4
    Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
    Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances in the treatment of acute lymphoblastic leukemia.
    Rafei H; Kantarjian HM; Jabbour EJ
    Leuk Lymphoma; 2019 Nov; 60(11):2606-2621. PubMed ID: 31092071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RNA sequencing unravels the genetics of refractory/relapsed T-cell acute lymphoblastic leukemia. Prognostic and therapeutic implications.
    Gianfelici V; Chiaretti S; Demeyer S; Di Giacomo F; Messina M; La Starza R; Peragine N; Paoloni F; Geerdens E; Pierini V; Elia L; Mancini M; De Propris MS; Apicella V; Gaidano G; Testi AM; Vitale A; Vignetti M; Mecucci C; Guarini A; Cools J; Foà R
    Haematologica; 2016 Aug; 101(8):941-50. PubMed ID: 27151993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.